Skip to content
Consult Lhasa logo
  • Our purpose
  • Our services
    • Impurity formation
    • Potentially mutagenic impurities
    • Nitrosamines
    • Non-mutagenic impurities
  • Our team
  • Testimonials
  • News
  • Blog
  • Join us
  • Contact
  • Our purpose
  • Our services
    • Impurity formation
    • Potentially mutagenic impurities
    • Nitrosamines
    • Non-mutagenic impurities
  • Our team
  • Testimonials
  • News
  • Blog
  • Join us
  • Contact

Consult Lhasa blog

Explore the latest insights from Consult Lhasa

Get in touch
Blog Filter
Consult Lhasa CEO and Lead Scientific Consultant, David Ponting, in discussion
26 June 2025
Author: Dr David Ponting, Ally Reeves
10 considerations for scientifically robust and defensible nitrosamine safety risk assessments

Sign up to our newsletter

Sign up
Consult Lhasa logo white
  • Home
  • Our purpose
  • Our team
  • Testimonials
  • News
  • Blog
  • Home
  • Our purpose
  • Our team
  • Testimonials
  • News
  • Blog
  • Home
  • Our purpose
  • Our team
  • Testimonials
  • News
  • Blog
  • Home
  • Our purpose
  • Our team
  • Testimonials
  • News
  • Blog
  • Impurity formation
  • Potentially mutagenic impurities
  • Nitrosamines
  • Non-mutagenic impurities
  • Impurity formation
  • Potentially mutagenic impurities
  • Nitrosamines
  • Non-mutagenic impurities
  • Impurity formation
  • Potentially mutagenic impurities
  • Nitrosamines
  • Non-mutagenic impurities
  • Impurity formation
  • Potentially mutagenic impurities
  • Nitrosamines
  • Non-mutagenic impurities
  • Contact us
  • Join us
  • Privacy policy
  • Cookie policy
  • Contact us
  • Join us
  • Privacy policy
  • Cookie policy
  • Contact us
  • Join us
  • Privacy policy
  • Cookie policy
  • Contact us
  • Join us
  • Privacy policy
  • Cookie policy
Consult Lhasa is a Lhasa Limited subsidiary | Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK
© 2025 Consult Lhasa Limited, All rights reserved | Company Registration Number: 14707253